Nat MedJClubAn iPSC-derived neural progenitor cell therapy for subacute spinal cord injury: a phase 1 trial with long-term follow-up.
Nature Medicine · · Clinical Trial, Phase I · Open access
An iPSC-derived neural progenitor cell therapy for subacute spinal cord injury: a phase 1 trial with long-term follow-up.
Sugai, Tsuji + more
Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's. The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.
Read the brief in JClub →